PRKACB Attenuates Chondrocyte Loss and Inflammation in Osteoarthritis

PRKACB can increase cell viability and reduce inflammation by activating the PKA/CREB signaling pathway, and PRKACB is a novel target for OA treatment.

Authors

Institutions

Publication Details

Journal
Immunity Inflammation and Disease
Published
2026-02-01
DOI
https://doi.org/10.1002/iid3.70342
Primary Topic
Osteoarthritis Treatment and Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PRKACB Attenuates Chondrocyte Loss and Inflammation in Osteoarthritis

Zhengmao Liu, Qijuan Zhang, Weidan Xiao
Immunity Inflammation and Disease
Osteoarthritis Treatment and Mechanisms
article

PRKACB Attenuates Chondrocyte Loss and Inflammation in Osteoarthritis

Zhengmao Liu, Qijuan Zhang, Weidan Xiao
article en

Abstract

PRKACB can increase cell viability and reduce inflammation by activating the PKA/CREB signaling pathway, and PRKACB is a novel target for OA treatment.

Immunity Inflammation and DiseaseVol. 14(2)
Wuhan Sports University (CN)
Openalex Percentile: Top 58%
Osteoarthritis Treatment and Mechanisms
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

PRKACB Attenuates Chondrocyte Loss and Inflammation in Osteoarthritis — Zhengmao Liu, Qijuan Zhang, et al. · Immunity Inflammation and Disease (2026) | TGRS Research Map | TGRS